Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

Dr. David Dodwell is a Senior Clinical Research Fellow. He came to Oxford after more than 20 years as a consultant working in the NHS based in Leeds and he has a major clinical and research interest in breast cancer.

He now works full time in NDPH within the ‘Benefits and Risks of Cancer Treatment Programme’ and the Early Breast Cancer Trialists’ Collaborative Group.

From the perspective of a clinician with much experience in clinical trials, he will discuss the progress that has been made in the management of breast cancer over the last few decades. He will also assess the strengths and limitations of randomized evidence in improving the management of patients.

Forthcoming events

The epidemiology of periportal fibrosis in the context of intestinal schistosomiasis

Monday, 09 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar rooms

Defeating Meningitis by 2023 Global Roadmap

Monday, 16 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar room 1

OxPop Festival of Global Health - The Cancer Conflict

Thursday, 19 October 2023, 5pm to 8pm @ Richard Doll Lecture Theatre, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF

Cancer Treatments: trust and information

Chronic infections and risk of NCDs in Chinese adults

Monday, 30 October 2023, 1pm to 2pm @ BBDI/OxPop Building seminar rooms

Metabolomics and diabetes in CKB and UKB

Thursday, 02 November 2023, 12pm to 1pm @ BDI/OxPop Building LG seminar room 0